Tweet Archive for hashtag “#Allergan” « page 3

Comparison and Overview of Currently Available Neurotoxins ncbi.nlm.nih.gov/pubmed/24587850 #Allergan #Merz #Ipsen #Valeant

5:07am Apr 22 2014 —

More infos on: Johnson & Johnson Ending Plans for Botox Rival online.wsj.com/news/articles/… botulinum toxin #Allergan #Ipsen #Valeant #Merz

10:34am Apr 14 2014 —

J&J said it terminated development of its experimental drug PurTox. Not a surprise #BTXA
firstwordpharma.com/node/1202735#a… #Allergan #Merz #Galderma

10:22am Apr 14 2014 —

RT @DermTimesNow: Experts tips on dosing & volume eq in #botulinumtoxin type A bit.ly/PsciQl #allergan #Merz #cosmeticdermatology

in reply to DermTimesNow — 9:54am Apr 13 2014 —

Skin Biomechanical Changes after Injection of Ona BoNTA: Assessment of Elasticity and Pliability. feedly.com/e/6-gQYCWt #Botox #Allergan

11:46am Mar 26 2014 —

Prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias ncbi.nlm.nih.gov/pubmed/23104985 #Allergan

12:26pm Mar 20 2014 —

Patient-reported outcomes of bimatoprost for eyelash growth: results from a RCT ncbi.nlm.nih.gov/pubmed/23873891 #Allergan #Latisse

12:24pm Mar 20 2014 —

Bimatoprost for Eyelash Growth in Japanese Subjects: Two Multicenter Controlled Studies ncbi.nlm.nih.gov/pubmed/24643895 #Allergan

12:21pm Mar 20 2014 —

RT @AESTHETiKA: #ICYMI #Allergan statement on #DoHResponse to #Keogh aestheticsjournal.com/news/item/alle… #BTXA #dermalfillers

in reply to aesthetika — 12:56pm Mar 3 2014 —

Is botulinum toxin diffusion dose dependent? Yes according this @JAMADerm study ncbi.nlm.nih.gov/pubmed/2410852… #Allergan #Ipsen #Valeant #BTXA

11:06am Feb 20 2014 —